Michael Hearne

Michael Hearne

Directeur Financier/CFO chez ODONATE, INC.

Fortune : 2 M $ au 30/09/2026

64 ans
Health Technology
Commercial Services
Consumer Services

Profil

Mr. Michael S.
Hearne
, CPA, is a Chief Financial Officer at Tang Capital Acquisition Corp., a Chief Financial Officer at Kezar Life Sciences, Inc., a Chief Financial Officer at Aurinia Pharmaceuticals, Inc. and a Chief Financial Officer at Odonate, Inc. Mr. Hearne was previously employed as a Chief Financial Officer & Secretary by La Jolla Pharmaceutical Co., a Partner by Weaver & Tidwell LLP, a Managing Director & Principal by Carson Private Capital, Inc., and a Partner by Rothstein, Kass & Co. LLC.
He received his undergraduate degree from Brigham Young University, an undergraduate degree from Texas A&M University and a graduate degree from Brigham Young University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
18/05/2026 116 144 ( 0,09 % ) 2 M $ 30/09/2026

Postes actifs de Michael Hearne

SociétésPosteDébut
ODONATE, INC. Directeur Financier/CFO 19/11/2018
AURINIA PHARMACEUTICALS INC. Directeur Financier/CFO 23/03/2026
KEZAR LIFE SCIENCES, INC. Directeur Financier/CFO 11/05/2026

Anciens postes connus de Michael Hearne

SociétésPosteFin
Corporate Officer/Principal 01/01/2015
Corporate Officer/Principal 01/01/2008
LA JOLLA PHARMACEUTICAL COMPANY Directeur Financier/CFO -
Private Equity Investor -
Voir l'expérience en détail de Michael Hearne

Formation de Michael Hearne

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

80

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Michael Hearne
🔇